South Korea Starts Onsite Inspections Of Essential Drug Reserves Amid Tension With North Korea
This article was originally published in PharmAsia News
Executive Summary
As tensions between South and North Korea simmer, South Korea is conducting its first on-site inspections of drug reserves since 2006.
You may also be interested in...
South Korea's LG Takes Shot At Vaccines Via In-licensing Deal With U.S. Novavax
SEOUL - South Korea's LG Life Sciences said next year it will start building a production plant in Osong, south of the capital city of Seoul, to produce cell-culture influenza vaccines based on the virus-like particle technology in-licensed from Novavax of the U.S
South Korean Government To Build New Flu Vaccine Plant As Part Of Campaign For "Vaccine Independence" From Global Giants
SEOUL - To avoid a recurrence of last year's challenge to secure flu vaccines during the A/H1N1 pandemic, South Korea's government has initiated a drive to bolster the nation's independent capacity to produce these vaccines
Early-Stage Idiopathic Pulmonary Fibrosis (IPF) Candidates Race to Phase III
Multiple IPF drugs are being rushed into Phase III based on early-stage signals of efficacy and safety presented at the ATS meeting. Scrip spoke with the University of Pittsburgh's Kevin Gibson about the candidates, trial design, combination therapy and limitations of current therapy.